Market-moving stories, structured for trading automations. Plug into Claude Desktop, Cursor, or your own agent in minutes.
Crawled and deduplicated across the open web. The strongest candidates get a full AI pass with a 1–10 relevance score and per-ticker analysis.
Distinct publisher domains scanned in the last 30 days.
Only the best clear the relevance floor with a verified ticker. The rest is filtered out.
Median from EDGAR publication to an enriched, ticker-tagged row, covering insider trades (Form 4), corporate actions (8-K) and foreign issuers' earnings releases (6-K).
All of it can come to you. News alerts land in Telegram, email, or a webhook the moment a story clears your filters, and the tickers, categories, and relevance threshold are yours to set.
"Claude, what moved NVDA today?"
alphai_news_search → MCP
Try it"Send only high-relevance earnings news for my watchlist."
/api/news/?category=earnings · min_relevance=7
Try it"Build a Telegram bot for market-moving news in 10 minutes."
/api/news/trending/ + your bot framework
Try it"Any insider buying in my watchlist this week?"
alphai_insider_news → MCP · /api/news/insider/
Try it"Feed my agent relevance-scored financial news via MCP."
OAuth 2.1 · News & watchlist tools · Streamable HTTP
Try itState Street's Technology Select Sector SPDR ETF (XLK) does not hold Alphabet, Amazon, Meta, Netflix, or Tesla. As of June 30, 2026, NVIDIA, Apple, and Microsoft made up 35.87% of the fund. XLK tracks a GICS-based index, excluding companies classified outside Information Technology. Investors seeking broad tech exposure may find XLK's concentration in three stocks a limitation.
S&P 500 and Nasdaq Composite closed at record highs on Tuesday, driven by expectations of strong corporate profits. Lamb Weston reported better-than-expected earnings, raising its full-year profit forecast. Analysts expect S&P 500 companies to show nearly 30% earnings growth. Bond yields eased, and oil prices stabilized, reducing inflation pressure. Constellation Energy and Option Care Health saw significant stock gains.
BioMarin Pharmaceutical (BMRN) reported a $283M Q3 IPR&D expense, reducing GAAP and non-GAAP EPS by $1.50. Non-GAAP EPS is estimated at $1.25. The expense impacts financial results for the quarter.
Michael Williams disclosed a 78.24% stake in Bravo Multinational Inc. (BRVO) via MWP Entertainment Group, giving him control and a board chair role. He filed a Schedule 13D on Oct. 06, 2026, after a Sept. 18, 2026 deal. MWP has an option to buy more shares, potentially increasing control.
U.S. crude oil stockpiles decreased by 2.1M barrels last week, according to the American Petroleum Institute, following a 1M barrel increase the prior week. The data may impact oil-related investments.
ArriVent BioPharma's average price target was reduced by analysts from $42.45 to $37.55, with a range of $18 to $50. This suggests a 32% upside from the Oct. 5 closing price. All 12 analysts maintain a 'Buy' rating.
Genmab A/S's average price target increased to $42 from $41.45 by 21 analysts, with a range of $30.93 to $58. This implies a 9% upside from the Oct. 5 closing price. The consensus rating remains 'Buy' among 27 analysts.
The same scored news feed that powers AlphAI is available as a REST API, and as an MCP server for Claude Desktop, Cursor, and any other agent host. Articles arrive enriched and linked to tickers in real time.
Dropping it into an existing stack? The Python and n8n quick starts are copy-paste.
curl https://api.alphai.io/api/news/ \
-H "Authorization: Bearer ${ALPHAI_API_KEY}" \
-G -d "symbol=NVDA"
# → {
# "results": [{
# "original": {
# "title": "Nvidia export curbs tighten...",
# "summary": "The White House is expected to...",
# "time_published": "2026-04-18T14:32:00Z"
# },
# "enrichment": {
# "category": "macro",
# "tickers": ["NVDA"],
# "relevance_score": 9
# }
# }, ...],
# "next_cursor": "MjAyNi0wNC0xOFQxNDozMjowMHw0Mg=="
# }Free reads the feed and probes the APIs. Paid plans drop the ads and scale up the rate.
Subscribe now and keep this rate for as long as you stay subscribed. We will not raise it for you.
Don’t want to watch the feed? Follow a ticker and we’ll deliver a daily digest of everything that clears your relevance bar, so you don’t have to check back.
Set up alerts